Nasal sinusitis, commonly called a sinus infection, is a condition characterised by inflammation or swelling of the tissue ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

In CRS with and without nasal polyps, medical treatment, including nasal and oral corticosteroids, is the first therapeutic option. The treatment of CRS still remains an unmet need ...

Patients with CRSwNP have a high burden of SCS use and associated health care costs, especially when they have comorbid asthma.

based on an analysis of (1) the occurrence of polyps and of allergy, (2) the anatomy and histology of nasal polyps, (3) the inflammation in nasal polyps, (4) the occurrence of positive allergy tests ...

In the case of nasal polyps or tumors, there is no way to prevent them from developing. The focus is on treatment when they do arise. Ear candles are hollowed-out fabric cones wrapped in wax. Some ...

Do you find yourself sneezing, itching or battling watery eyes as the seasons change? If so, you may have a pollen ...

GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The company said this morning ...

When you inhale an allergen, your immune system sounds the alarm and releases chemicals (histamines for example) that cause inflammation in your nasal membranes and eyes ... Medication and surgery (in ...

"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, as the caregiver team navigates the course of a disease." Recent advances ...